Inspirion Wealth Advisors LLC Grows Position in CME Group Inc. (NASDAQ:CME)

Inspirion Wealth Advisors LLC grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 2.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,080 shares of the financial services provider’s stock after purchasing an additional 80 shares during the quarter. Inspirion Wealth Advisors LLC’s holdings in CME Group were worth $606,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the stock. Stratos Wealth Partners LTD. increased its stake in CME Group by 5.6% during the 4th quarter. Stratos Wealth Partners LTD. now owns 2,589 shares of the financial services provider’s stock worth $545,000 after buying an additional 137 shares during the period. International Assets Investment Management LLC acquired a new position in shares of CME Group in the fourth quarter worth about $27,986,000. Allspring Global Investments Holdings LLC lifted its stake in shares of CME Group by 169.6% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 82,371 shares of the financial services provider’s stock worth $17,347,000 after acquiring an additional 51,818 shares in the last quarter. Sequoia Financial Advisors LLC boosted its holdings in CME Group by 76.4% in the fourth quarter. Sequoia Financial Advisors LLC now owns 5,938 shares of the financial services provider’s stock valued at $1,250,000 after purchasing an additional 2,571 shares during the last quarter. Finally, GHP Investment Advisors Inc. grew its stake in CME Group by 6.2% during the 4th quarter. GHP Investment Advisors Inc. now owns 15,486 shares of the financial services provider’s stock valued at $3,261,000 after purchasing an additional 903 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insiders Place Their Bets

In related news, Director Terry L. Savage sold 2,500 shares of the stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $210.65, for a total value of $526,625.00. Following the completion of the transaction, the director now owns 17,441 shares in the company, valued at approximately $3,673,946.65. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Charles P. Carey sold 3,000 shares of the business’s stock in a transaction on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the sale, the director now owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Terry L. Savage sold 2,500 shares of the firm’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $210.65, for a total value of $526,625.00. Following the transaction, the director now directly owns 17,441 shares of the company’s stock, valued at approximately $3,673,946.65. The disclosure for this sale can be found here. In the last quarter, insiders sold 7,150 shares of company stock worth $1,455,401. 0.30% of the stock is owned by company insiders.

CME Group Stock Performance

Shares of CME Group stock traded up $1.51 during trading on Friday, hitting $206.66. 1,011,306 shares of the stock were exchanged, compared to its average volume of 1,974,399. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.01 and a current ratio of 1.02. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $223.80. The stock’s fifty day moving average is $197.97 and its 200 day moving average is $207.00. The stock has a market cap of $74.41 billion, a PE ratio of 23.51, a P/E/G ratio of 6.27 and a beta of 0.52.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping the consensus estimate of $2.53 by $0.03. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. CME Group’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.30 EPS. As a group, sell-side analysts anticipate that CME Group Inc. will post 9.8 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.23%. The ex-dividend date is Monday, September 9th. CME Group’s payout ratio is currently 52.33%.

Analyst Ratings Changes

Several research firms have recently weighed in on CME. Barclays boosted their target price on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 25th. Keefe, Bruyette & Woods upped their price objective on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. Piper Sandler decreased their target price on CME Group from $235.00 to $225.00 and set an “overweight” rating for the company in a research report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft dropped their price target on CME Group from $195.00 to $193.00 and set a “hold” rating on the stock in a research report on Thursday, July 25th. Finally, Bank of America raised their price objective on CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a research note on Thursday, April 25th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, CME Group presently has an average rating of “Hold” and a consensus target price of $212.64.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.